With efforts to tackle fake drugs in Africa increasing, the WHO's director-general speaks on the need to shorten the supply chain with local manufacturing.
The CDSCO has accused international “vested interests” of labelling counterfeit drugs as “made in India” to damage the reputation of the country’s pharmaceutical industry and launched a scheme to reward people who report fakes.
The EFPIA has selected software firm Solidsoft for its anti-counterfeit European Medicines Verification System (EMVS) powered by Microsoft's cloud-based platform Windows Azure.
Only multiple anti-counterfeiting strategies are able to beat increasingly sophisticated criminals, according to a seminar on anti-counterfeiting at the recent AAPS trade event in New Orleans.
The NAFDAC has banned 22 firms that it says are involved in the manufacture of fake drugs from ever again selling pharmaceuticals in Nigeria, as part of a countrywide clampdown.
Three more individuals have been sentenced following last month's
exposure of the largest counterfeit drugs conspiracy ever to be
encountered in the UK.
Pharmaceutical companies and governments are not doing enough to
combat the problem of drug counterfeiting, which is developing into
an international health crisis, claim researchers.
The Indian government has proposed draconian new penalties for
individuals found making counterfeit pharmaceuticals, after a
number of fatalities associated with bootleg drugs.
